Compared to the general population, individuals with incident hospital-based cannabis use disorder care have an increased risk of death.

Hepatorenal syndrome, acute tubular necrosis, and pneumonia may increase the need for renal replacement therapy in patients with cirrhosis and acute kidney injury.

The FDA has approved Gvoke VialDx (glucagon) for IV use as a diagnostic aid during radiologic examinations to temporarily inhibit movement of the GI tract.

The National Institutes of Health will no longer fund new research on how climate change affects people’s health.

Colorectal cancer is tied to an increased risk for cardiovascular mortality, especially in individuals younger than 50 years.

Colorectal cancer was found to be the most common malignancy and cause of death among patients with classic familial adenomatous polyposis.

The US Centers for Disease Control and Prevention is facing major changes, with five senior leaders stepping down.

The FDA has granted traditional approval to Keytruda (pembrolizumab) in combination with trastuzumab and chemotherapy for HER2-positive gastric or gastroesophageal junction adenocarcinoma.

Dozens of research projects focused on LGBTQ health have been canceled by the US government, alarming scientists.

The FDA launched the Chemical Contaminants Transparency Tool, a database to evaluate potential health risks of contaminants in foods.

Fragmented sleep is associated with the pathogenesis of metabolic dysfunction-associated steatotic liver disease (MASLD).

Among women with Crohn disease and prior perianal surgery, vaginal delivery was not associated with more adverse maternal outcomes than c-section.